1
Investors
About
IRLAB Therapeutics AB is a clinical-stage biotechnology company focused on developing novel treatments for central nervous system disorders such as Parkinson's disease.
Explore IRLAB Therapeutics AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.